Onconetix, Inc. — Director's Dealing 2022

Feb 18, 2022

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Blue Water Vaccines Inc. (BWV)
CIK: 0001782107
Period of Report: 2022-02-17

Reporting Person: Henderson Erin (Chief Business Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option	$0.01	2030-04-02	Common Stock, par value $0.00001 per share (45920)		Direct

Footnotes

F1: The option vests and becomes exercisable as to 25% on April 2, 2021 and as to the remainder of the shares in 36 equal monthly installments thereafter.